Nuage Therapeutics Appoints Dr. Stuart Hughes CEO and Vanessa Malier as Chair
Nuage Therapeutics applying its proprietary technology to advance a pipeline of novel agents targeting oncogenic transcription factors.
April 1, 2025
EXECUTIVES
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
Olga Uspenskaya-Cadoz Appointed Chief Medical Officer of VectorY Therapeutics
Dr. Uspenskaya-Cadoz brings two decades of experience in neurology, gene therapy, and clinical development, enhancing VectorY’s leadership in developing transformative treatments for neurodegenerative conditions.
April 1, 2025
Operation Warp Speed Leader Tapped as Panther Life Sciences’ New R&D Chief | The Appointment of Dr Matthew Hepburn to Expand Panther’s Leadership For Next Generation Immune-Mediated Therapies
In this role, Dr Martin Hepburn will drive Panther’s strategic commitment to commercialize its patented MAP technology, with a primary focus on reducing time-to-market and delivering the first commercial product to customers within the next two years.
March 27, 2025
Michael Andersen Joins Vektor Medical as Vice President, Quality Assurance and Regulatory Affairs
Michael Andersen brings more than 20 years of commercial leadership experience in electrophysiology and medtech, with a strong track record of market development, sales execution, and strategic growth.
March 17, 2025
Abbas Kazimi Steps Up as Dynamic CEO of Nimbus Therapeutics
“I am honored to lead Nimbus at this pivotal time in the company’s evolution,” said Abbas Kazimi. “Our robust pipeline, anchored by promising programs like our WRN and SIK inhibitors, and our ongoing collaboration with Lilly, continues to validate our approach and strengthen our position in the industry. I’m particularly excited about what Nimbus will continue to discover and advance, as we leverage our computational drug discovery engine to bring innovative medicines for patients.”
March 7, 2025
Mirva Ekman Appointed Quality Director & Member of the Management Team at Bioretec
Mirva Ekman over 20 years of experience in quality and regulatory leadership.
March 7, 2025
